avd-10q_20160930.htm

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 10-Q

 

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

FOR THE QUARTERLY PERIOD ENDED September 30, 2016

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

FOR THE TRANSITION PERIOD FROM                      TO                      

Commission file number 001-13795

 

AMERICAN VANGUARD CORPORATION

 

 

Delaware

95-2588080

(State or other jurisdiction of

Incorporation or organization)

(I.R.S. Employer

Identification Number)

 

 

4695 MacArthur Court, Newport Beach, California

92660

(Address of principal executive offices)

(Zip Code)

(949) 260-1200

(Registrant’s telephone number, including area code)

(Former name, former address and former fiscal year, if changed since last report)

 

Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.    Yes      No  

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).    Yes      No  

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, or a non-accelerated filer. See definition of “accelerated filer and large accelerated filer” in Rule 12b-2 of the Exchange Act. (Check one):

 

Large Accelerated Filer

 

Accelerated Filer

Non-Accelerated Filer

 

Smaller reporting company

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).    Yes      No  

Indicate the number of shares outstanding of each of the issuer’s classes of common stock, as of the latest practicable date.

Common Stock, $.10 Par Value—29,360,039 shares as of October 25, 2016.

 

 

 

 

 


 

AMERICAN VANGUARD CORPORATION

INDEX

 

 

 

 

Page Number

PART I—FINANCIAL INFORMATION

 

 

 

 

 

 

Item 1.

Financial Statements (unaudited)

 

 

 

 

 

 

 

Condensed Consolidated Statements of Operations for the three months and nine months ended September 30, 2016 and 2015

 

3

 

 

 

 

 

Condensed Consolidated Balance Sheets as of September 30, 2016 and December 31, 2015

 

4

 

 

 

 

 

Condensed Consolidated Statements of Stockholders’ Equity for the three months ended March 31, 2016, June 30, 2016, and September 30, 2016

 

5

 

 

 

 

 

Condensed Consolidated Statements of Comprehensive Income for the three months and nine months ended September 30, 2016 and 2015

 

6

 

 

Condensed Consolidated Statements of Cash Flows for the nine months ended September 30, 2016 and 2015

 

7

 

 

 

 

 

Notes to Condensed Consolidated Financial Statements

 

8

 

 

 

 

Item 2.

Management’s Discussion and Analysis of Financial Condition and Results of Operations

 

20

 

 

 

 

Item 3.

Quantitative and Qualitative Disclosures About Market Risk

 

29

 

 

 

 

Item 4.

Controls and Procedures

 

29

 

 

 

PART II—OTHER INFORMATION

 

30

 

 

 

 

Item 1.

Legal Proceedings

 

30

 

 

 

 

Item 6.

Exhibits

 

31

 

 

 

SIGNATURES

 

32

 

 

2


 

PART I. FINANCIAL INFORMATION

Item 1.

FINANCIAL STATEMENTS

 

AMERICAN VANGUARD CORPORATION AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(In thousands, except per share data)

(Unaudited)

 

 

 

For the three months

ended September 30

 

 

For the nine months

ended September 30

 

 

 

2016

 

 

2015

 

 

2016

 

 

2015

 

Net sales

 

$

82,447

 

 

$

72,486

 

 

$

224,645

 

 

$

205,574

 

Cost of sales

 

 

49,461

 

 

 

41,053

 

 

 

132,761

 

 

 

124,370

 

Gross profit

 

 

32,986

 

 

 

31,433

 

 

 

91,884

 

 

 

81,204

 

Operating expenses

 

 

28,255

 

 

 

26,059

 

 

 

77,429

 

 

 

74,325

 

Operating income

 

 

4,731

 

 

 

5,374

 

 

 

14,455

 

 

 

6,879

 

Interest expense

 

 

301

 

 

 

638

 

 

 

1,304

 

 

 

1,941

 

Income before provision for income taxes and loss on

   equity investment

 

 

4,430

 

 

 

4,736

 

 

 

13,151

 

 

 

4,938

 

Income tax expense

 

 

1,409

 

 

 

1,643

 

 

 

3,672

 

 

 

958

 

Income before loss on equity investment

 

 

3,021

 

 

 

3,093

 

 

 

9,479

 

 

 

3,980

 

Net loss from equity investment

 

 

(180

)

 

 

(389

)

 

 

(309

)

 

 

(580

)

Net income

 

 

2,841

 

 

 

2,704

 

 

 

9,170

 

 

 

3,400

 

Add back net loss (income) attributable to non-controlling interest

 

 

36

 

 

 

68

 

 

 

(253

)

 

 

204

 

Net income attributable to American Vanguard

 

$

2,877

 

 

$

2,772

 

 

$

8,917

 

 

$

3,604

 

Earnings per common share—basic

 

$

0.10

 

 

$

0.10

 

 

$

0.31

 

 

$

0.13

 

Earnings per common share—assuming dilution

 

$

0.10

 

 

$

0.09

 

 

$

0.30

 

 

$

0.12

 

Weighted average shares outstanding—basic

 

 

28,957

 

 

 

28,753

 

 

 

28,886

 

 

 

28,653

 

Weighted average shares outstanding—assuming dilution

 

 

29,496

 

 

 

29,289

 

 

 

29,385

 

 

 

29,208

 

 

See notes to the condensed consolidated financial statements.

 

 

 

3


 

AMERICAN VANGUARD CORPORATION AND SUBSIDIARIES

CONDENSED CONSOLIDATED BALANCE SHEETS

(In thousands, except share data)

(Unaudited)

ASSETS

 

 

 

Sept. 30,

2016

 

 

Dec. 31,

2015

 

Current assets:

 

 

 

 

 

 

 

 

Cash and cash equivalents

 

$

6,594

 

 

$

5,524

 

Receivables:

 

 

 

 

 

 

 

 

Trade, net of allowance for doubtful accounts of $159 and $423, respectively

 

 

91,091

 

 

 

72,835

 

Other

 

 

3,500

 

 

 

2,554

 

Total receivables

 

 

94,591

 

 

 

75,389

 

Inventories

 

 

141,678

 

 

 

136,477

 

Prepaid expenses

 

 

12,270

 

 

 

11,172

 

Income taxes receivable

 

 

 

 

 

168

 

Deferred income tax assets

 

 

8,101

 

 

 

8,101

 

Total current assets

 

 

263,234

 

 

 

236,831

 

Property, plant and equipment, net

 

 

47,760

 

 

 

47,972

 

Intangible assets, net of applicable amortization

 

 

123,420

 

 

 

129,160

 

Other assets

 

 

28,695

 

 

 

29,576

 

Total assets

 

$

463,109

 

 

$

443,539

 

 

 

 

 

 

 

 

 

 

LIABILITIES AND STOCKHOLDERS’ EQUITY

 

Current liabilities:

 

 

 

 

 

 

 

 

Current installments of other notes payable

 

$

-

 

 

$

55

 

Current installments of other liabilities

 

 

74

 

 

 

514

 

Accounts payable

 

 

23,268

 

 

 

15,343

 

Deferred revenue

 

 

41

 

 

 

8,888

 

Accrued program costs

 

 

74,907

 

 

 

44,371

 

Accrued expenses and other payables

 

 

10,209

 

 

 

7,111

 

Income taxes payable

 

 

1,269

 

 

 

 

Total current liabilities

 

 

109,768

 

 

 

76,282

 

Long-term debt and other notes payable, excluding current installments

 

 

44,488

 

 

 

68,321

 

Other liabilities, excluding current installments

 

 

3,036

 

 

 

3,054

 

Deferred income tax liabilities

 

 

27,556

 

 

 

27,556

 

Total liabilities

 

 

184,848

 

 

 

175,213

 

Commitments and contingent liabilities

 

 

 

 

 

 

 

 

Stockholders' Equity:

 

 

 

 

 

 

 

 

Preferred stock, $.10 par value per share; authorized 400,000 shares; none issued

 

 

 

 

 

 

Common stock, $.10 par value per share; authorized 40,000,000 shares; issued 31,807,223 shares at September 30, 2016 and 31,638,225 shares at December 31, 2015

 

 

3,182

 

 

 

3,164

 

Additional paid-in capital

 

 

70,458

 

 

 

68,534

 

Accumulated other comprehensive loss

 

 

(4,429

)

 

 

(3,541

)

Retained earnings

 

 

217,135

 

 

 

208,507

 

 

 

 

286,346

 

 

 

276,664

 

Less treasury stock, at cost, 2,450,634 shares at September 30, 2016 and

   December 31, 2015

 

 

(8,269

)

 

 

(8,269

)

American Vanguard Corporation stockholders’ equity

 

 

278,077

 

 

 

268,395

 

Non-controlling interest

 

 

184

 

 

 

(69

)

Total stockholders’ equity

 

 

278,261

 

 

 

268,326

 

Total liabilities and stockholders' equity

 

$

463,109

 

 

$

443,539

 

See notes to the condensed consolidated financial statements.

 

 

 

 

4


 

 

AMERICAN VANGUARD CORPORATION AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY

(In thousands, except share data)

For The Three Months Ended March 31, 2016, June 30, 2016, and September 30, 2016

(Unaudited)

 

 

 

Common Stock

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Treasury Stock

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Shares

 

 

Amount

 

 

Additional

Paid-in

Capital

 

 

Accumulated

Other

Comprehensive

Loss

 

 

Retained

Earnings

 

 

Shares

 

 

Amount

 

 

AVD

Total

 

 

Non-

Controlling

Interest

 

 

Total

 

Balance, December 31, 2015

 

 

31,638,225

 

 

$

3,164

 

 

$

68,534

 

 

$

(3,541

)

 

$

208,507

 

 

 

2,450,634

 

 

$

(8,269

)

 

$

268,395

 

 

$

(69

)

 

$

268,326

 

Stocks issued under ESPP

 

 

19,627

 

 

 

2

 

 

 

269

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

271

 

 

 

 

 

 

271

 

Foreign currency translation adjustment, net

 

 

 

 

 

 

 

 

 

 

 

85

 

 

 

 

 

 

 

 

 

 

 

 

85

 

 

 

 

 

 

85

 

Stock based compensation

 

 

 

 

 

 

 

 

456

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

456

 

 

 

 

 

 

456

 

Stock options exercised and grants, vesting and

   forfeited restricted stock units

 

 

(61,550

)

 

 

(6

)

 

 

(580

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(586

)

 

 

 

 

 

(586

)

Excess tax benefits from share based

   payment arrangements

 

 

 

 

 

 

 

 

35

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

35

 

 

 

 

 

 

35

 

Net income

 

 

 

 

 

 

 

 

 

 

 

 

 

 

2,794

 

 

 

 

 

 

 

 

 

2,794

 

 

 

153

 

 

 

2,947

 

Balance, March 31, 2016

 

 

31,596,302

 

 

$

3,160

 

 

$

68,714

 

 

$

(3,456

)

 

$

211,301

 

 

 

2,450,634

 

 

$

(8,269

)

 

$

271,450

 

 

$

84

 

 

$

271,534

 

Cash dividends on common stock ($0.01

   per share)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(289

)

 

 

 

 

 

 

 

 

(289

)

 

 

 

 

 

(289

)

Foreign currency translation adjustment, net

 

 

 

 

 

 

 

 

 

 

 

(537

)

 

 

 

 

 

 

 

 

 

 

 

(537

)

 

 

 

 

 

(537

)

Stock based compensation

 

 

 

 

 

 

 

 

612

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

612

 

 

 

 

 

 

612

 

Stock options exercised and grants, vesting and

   forfeited restricted stock units

 

 

192,342

 

 

 

20

 

 

 

100

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

120

 

 

 

 

 

 

120

 

Excess tax benefits from share based

   payment arrangements

 

 

 

 

 

 

 

 

12

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

12

 

 

 

 

 

 

12

 

Net income

 

 

 

 

 

 

 

 

 

 

 

 

 

 

3,246

 

 

 

 

 

 

 

 

 

3,246

 

 

 

136

 

 

 

3,382

 

Balance, June 30, 2016

 

 

31,788,644

 

 

$

3,180

 

 

$

69,438

 

 

$

(3,993

)

 

$

214,258

 

 

 

2,450,634

 

 

$

(8,269

)

 

$

274,614

 

 

$

220

 

 

$

274,834

 

Stocks issued under ESPP

 

 

23,103

 

 

 

2

 

 

 

289

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

291

 

 

 

 

 

 

291

 

Foreign currency translation adjustment, net

 

 

 

 

 

 

 

 

 

 

 

(436

)

 

 

 

 

 

 

 

 

 

 

 

(436

)

 

 

 

 

 

(436

)

Stock based compensation

 

 

 

 

 

 

 

 

588

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

588

 

 

 

 

 

 

588

 

Stock options exercised and grants, vesting and

   forfeited restricted stock units

 

 

(4,524

)

 

 

 

 

 

108

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

108

 

 

 

 

 

 

108

 

Excess tax benefits from share based

   payment arrangements

 

 

 

 

 

 

 

 

35

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

35

 

 

 

 

 

 

35

 

Net income (loss)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

2,877

 

 

 

 

 

 

 

 

 

2,877

 

 

 

(36

)

 

 

2,841

 

Balance, September 30, 2016

 

 

31,807,223

 

 

$

3,182

 

 

$

70,458

 

 

$

(4,429

)

 

$

217,135

 

 

 

2,450,634

 

 

$

(8,269

)

 

$

278,077

 

 

$

184

 

 

$

278,261

 

 

See notes to the condensed consolidated financial statements.

 

 

 

5


 

AMERICAN VANGUARD CORPORATION AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME

(In thousands)

(Unaudited)

 

 

 

 

 

 

For the three months

ended September 30

 

 

For the nine months

ended September 30

 

 

 

2016

 

 

2015

 

 

2016

 

 

2015

 

Net income attributable to American Vanguard

 

$

2,877

 

 

$

2,772

 

 

$

8,917

 

 

$

3,604

 

Foreign currency translation adjustment

 

 

(436

)

 

 

(897

)

 

 

(888

)

 

 

(1,468

)

Comprehensive income

 

$

2,441

 

 

$

1,875

 

 

$

8,029

 

 

$

2,136

 

 

 

 

 

 

See notes to the condensed consolidated financial statements.

 

 

6


 

AMERICAN VANGUARD CORPORATION AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(In thousands)

For The Nine Months Ended September 30, 2016 and 2015

(Unaudited)

 

Increase (decrease) in cash

 

2016

 

 

2015

 

Cash flows from operating activities:

 

 

 

 

 

 

 

 

Net income

 

$

9,170

 

 

$

3,400

 

Adjustments to reconcile net income to net cash provided by operating

   activities:

 

 

 

 

 

 

 

 

Depreciation and amortization of fixed and intangible assets

 

 

12,367

 

 

 

12,190

 

Amortization of other long term assets

 

 

3,935

 

 

 

3,992

 

Amortization of discounted liabilities

 

 

28

 

 

 

118

 

Stock-based compensation

 

 

1,656

 

 

 

2,943

 

Tax benefit from exercise of stock options

 

 

(82

)

 

 

(8

)

Operating loss from equity method investment

 

 

309

 

 

 

580

 

Changes in assets and liabilities associated with operations:

 

 

 

 

 

 

 

 

Increase in net receivables

 

 

(19,202

)

 

 

(6,172

)

(Increase) decrease in inventories

 

 

(5,201

)

 

 

4,135

 

(Increase) decrease in prepaid expenses and other assets

 

 

(1,011

)

 

 

1,143

 

Decrease in income tax receivable/payable, net

 

 

1,519

 

 

 

4,739

 

Increase in accounts payable

 

 

7,925

 

 

 

3,010

 

Decrease in deferred revenue

 

 

(8,847

)

 

 

(860

)

Increase in program payables

 

 

30,536

 

 

 

20,982

 

Increase in other payables and accrued expenses

 

 

3,098

 

 

 

1,615

 

Net cash provided by operating activities

 

 

36,200

 

 

 

51,807

 

Cash flows from investing activities:

 

 

 

 

 

 

 

 

Capital expenditures

 

 

(6,122

)

 

 

(5,196

)

Investments

 

 

(3,283

)

 

 

(125

)

Acquisitions of product lines and other intangible assets

 

 

(224

)

 

 

(36,435

)

Net cash used in investing activities

 

 

(9,629

)

 

 

(41,756

)

Cash flows from financing activities:

 

 

 

 

 

 

 

 

Net payments under line of credit agreement

 

 

(24,000

)

 

 

(16,120

)

Increase in other notes payable

 

 

 

 

 

10,000

 

Payments on other long-term liabilities

 

 

(541

)

 

 

(1,252

)

Tax benefit from exercise of stock options

 

 

82

 

 

 

8

 

Payment of cash dividends

 

 

(289

)

 

 

(1,141

)

Net proceeds from the issuance of common stock (sale of stock under ESPP and

   exercise of stock options)

 

 

204

 

 

 

254

 

Net cash used in financing activities

 

 

(24,544

)

 

 

(8,251

)

Net increase in cash and cash equivalents

 

 

2,027

 

 

 

1,800

 

Cash and cash equivalents at beginning of period

 

 

5,524

 

 

 

4,885

 

Effect of exchange rate changes on cash and cash equivalents

 

 

(957

)

 

 

(1,256

)

Cash and cash equivalents at end of period

 

$

6,594

 

 

$

5,429

 

 

See notes to the condensed consolidated financial statements.

 

 

 

7


 

AMERICAN VANGUARD CORPORATION AND SUBSIDIARIES

Notes to Condensed Consolidated Financial Statements

(In thousands, except share data)

(Unaudited)

 

1. The accompanying unaudited condensed consolidated financial statements of American Vanguard Corporation and Subsidiaries (“AVD” or “Company”) have been prepared in accordance with generally accepted accounting principles in the United States of America for interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by generally accepted accounting principles in the United States of America for complete financial statements. In the opinion of management, all adjustments (consisting of normal recurring accruals) considered necessary for a fair presentation have been included. Operating results for the three and nine months ended September 30, 2016 are not necessarily indicative of the results that may be expected for the year ending December 31, 2016. For further information, refer to the consolidated financial statements and notes thereto included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2015.

 

 

2. Property, plant and equipment at September 30, 2016 and December 31, 2015 consists of the following:

 

 

 

September 30,

2016

 

 

December 31,

2015

 

Land

 

$

2,458

 

 

$

2,458

 

Buildings and improvements

 

 

15,067

 

 

 

14,726

 

Machinery and equipment

 

 

117,140

 

 

 

113,506

 

Office furniture, fixtures and equipment

 

 

4,857

 

 

 

4,997

 

Automotive equipment

 

 

383

 

 

 

491

 

Construction in progress

 

 

5,398

 

 

 

3,413

 

 

 

 

145,303

 

 

 

139,591

 

Less accumulated depreciation

 

 

(97,543

)

 

 

(91,619

)

 

 

$

47,760

 

 

$

47,972

 

 

For the three months and nine months periods ended September 30, 2016, the Company recognized depreciation expense related to property, plant and equipment of $2,021 and $6,334, respectively.   During the nine months ended September 30, 2016 and 2015, the Company eliminated from assets and accumulated depreciation $410 and $388 of fully depreciated assets, respectively.  The Company recognized depreciation expense related to property, plant and equipment of $2,231 and $6,762 for the three months and nine months periods ended September 30, 2015, respectively.  

Substantially all of the Company’s assets are pledged as collateral with its banks.

 

 

3. Inventories are stated at the lower of cost or market. Cost is determined using the first-in, first-out method. The components of inventories consist of the following:

 

 

 

September 30,

2016

 

 

December 31,

2015

 

Finished products

 

$

123,311

 

 

$

120,456

 

Raw materials

 

 

18,367

 

 

 

16,021

 

 

 

$

141,678

 

 

$

136,477

 

 

 

 

8


 

4. Based on similar economic and operational characteristics, the Company’s business is aggregated into one reportable segment. Selective enterprise information is as follows:

 

 

 

Three Months Ended

September 30

 

 

Nine Months Ended

September 30

 

 

 

2016

 

 

2015

 

 

2016

 

 

2015

 

Net sales:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Insecticides

 

$

25,478

 

 

$

23,539

 

 

$

89,496

 

 

$

85,484

 

Herbicides/soil fumigants/fungicides

 

 

34,242

 

 

 

32,682

 

 

 

80,009

 

 

 

71,973

 

Other, including plant growth regulators

 

 

13,328

 

 

 

7,420

 

 

 

23,148

 

 

 

23,497

 

Crop

 

 

73,048

 

 

 

63,641

 

 

 

192,653

 

 

 

180,954

 

Non-crop

 

 

9,399

 

 

 

8,845

 

 

 

31,992

 

 

 

24,620

 

Total net sales

 

$

82,447

 

 

$

72,486

 

 

$

224,645

 

 

$

205,574

 

Net sales:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

US

 

$

60,033

 

 

$

53,167

 

 

$

161,661

 

 

$

146,231

 

International

 

 

22,414

 

 

 

19,319

 

 

 

62,984

 

 

 

59,343

 

Total net sales

 

$

82,447

 

 

$

72,486

 

 

$

224,645

 

 

$

205,574

 

 

 

5. Accrued Program Costs—In accordance with Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) 605, the Company classifies certain payments to its customers as a reduction of sales revenues. The Company describes these payments as “Programs.” Programs are a critical part of doing business in the US agricultural chemicals business market place. For accounting purposes, Programs are recorded as a reduction in gross sales and include market pricing adjustments, volume take up or other key performance indicator driven payments, made to distributors, retailers or growers at the end of a growing season. Each quarter management compares individual sale transactions with published programs to determine what program liability has been incurred. Once this initial calculation is made for the specific quarter, sales and marketing management, along with executive and financial management, review the accumulated program balance and make assessments of whether or not customers are tracking in a manner that indicates that they will meet the requirements set out in the terms and conditions attached to each Program. If management believes that customers are falling short of or exceeding their annual goals, then periodic adjustments will be made to the accumulated accrual to properly reflect the Company’s best estimate of the liability at the balance sheet date. The majority of adjustments are made at the end of the crop season, at which time customer performance can be fully assessed. Programs are paid out predominantly on an annual basis, usually in the final quarter of the financial year or the first quarter of the following year.  During the three and nine months ended September 30, 2016 and 2015, no significant change in estimates was recorded.

 

 

6. The Company has declared and paid the following cash dividends in the period covered by this Form 10-Q:

 

Declaration Date

 

Record Date

 

Distribution Date

 

Dividend

Per Share

 

 

Total

Paid

 

June 13, 2016

 

June 30, 2016

 

July 12, 2016

 

$

0.01